Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.
Saved in:
| Title: | Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. |
|---|---|
| Authors: | Traweek RS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Zoghbi M; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Lazcano R; Department of Pathology, Massachusetts General Hospital, Boston, USA., Cope BM; Department of Surgery, Keesler Medical Center, Biloxi, USA., Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Farooqi A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Yoder AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Guadagnolo BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ingram DR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Wani K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Shamsutdinova D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Scally CP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Torres KE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Hunt KK; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Nakazawa MS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Nassif Haddad EF; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: efnassif@mdanderson.org. |
| Source: | ESMO open [ESMO Open] 2025 Jul; Vol. 10 (7), pp. 105493. Date of Electronic Publication: 2025 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40561658 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Traweek+RS%22">Traweek RS</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Zoghbi+M%22">Zoghbi M</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Lazcano+R%22">Lazcano R</searchLink>; Department of Pathology, Massachusetts General Hospital, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Cope+BM%22">Cope BM</searchLink>; Department of Surgery, Keesler Medical Center, Biloxi, USA.<br /><searchLink fieldCode="AU" term="%22Bishop+AJ%22">Bishop AJ</searchLink>; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Farooqi+A%22">Farooqi A</searchLink>; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Mitra+D%22">Mitra D</searchLink>; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+AK%22">Yoder AK</searchLink>; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Guadagnolo+BA%22">Guadagnolo BA</searchLink>; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ingram+DR%22">Ingram DR</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Wani+K%22">Wani K</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Shamsutdinova+D%22">Shamsutdinova D</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Scally+CP%22">Scally CP</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Keung+EZ%22">Keung EZ</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Torres+KE%22">Torres KE</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Hunt+KK%22">Hunt KK</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ratan+R%22">Ratan R</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Livingston+JA%22">Livingston JA</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Nakazawa+MS%22">Nakazawa MS</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Araujo+DM%22">Araujo DM</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ravi+V%22">Ravi V</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Zarzour+MA%22">Zarzour MA</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Somaiah+N%22">Somaiah N</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Roland+CL%22">Roland CL</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Nassif+Haddad+EF%22">Nassif Haddad EF</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: efnassif@mdanderson.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2025 Jul; Vol. 10 (7), pp. 105493. <i>Date of Electronic Publication: </i>2025 Jun 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40561658 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.esmoop.2025.105493 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105493 Titles: – TitleFull: Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Traweek RS – PersonEntity: Name: NameFull: Zoghbi M – PersonEntity: Name: NameFull: Lazcano R – PersonEntity: Name: NameFull: Cope BM – PersonEntity: Name: NameFull: Bishop AJ – PersonEntity: Name: NameFull: Farooqi A – PersonEntity: Name: NameFull: Mitra D – PersonEntity: Name: NameFull: Yoder AK – PersonEntity: Name: NameFull: Guadagnolo BA – PersonEntity: Name: NameFull: Ingram DR – PersonEntity: Name: NameFull: Wani K – PersonEntity: Name: NameFull: Shamsutdinova D – PersonEntity: Name: NameFull: Lazar AJ – PersonEntity: Name: NameFull: Wang WL – PersonEntity: Name: NameFull: Scally CP – PersonEntity: Name: NameFull: Keung EZ – PersonEntity: Name: NameFull: Torres KE – PersonEntity: Name: NameFull: Hunt KK – PersonEntity: Name: NameFull: Ratan R – PersonEntity: Name: NameFull: Livingston JA – PersonEntity: Name: NameFull: Nakazawa MS – PersonEntity: Name: NameFull: Araujo DM – PersonEntity: Name: NameFull: Patel S – PersonEntity: Name: NameFull: Ravi V – PersonEntity: Name: NameFull: Conley AP – PersonEntity: Name: NameFull: Zarzour MA – PersonEntity: Name: NameFull: Somaiah N – PersonEntity: Name: NameFull: Roland CL – PersonEntity: Name: NameFull: Nassif Haddad EF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2025 Jul Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2059-7029 Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: ESMO open Type: main |
| ResultId | 1 |